All the news Showing 10 of 213 articles from: Pharmaceutical industryGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Major hep B players Gilead and Vir join forces to find a cure Fierce Biotech / 18 January 2021 South Africa: Breakthrough hepatitis C medicines remain in regulatory limbo Daily Maverick / 04 August 2020 Gilead axes $445M Precision Biosciences gene therapy hep B pact Fierce Biotech / 14 July 2020 'Another swing, another miss' for Gilead as NASH combo flops in phase 2 Fierce Biotech / 16 December 2019 Pharma sells states on ‘Netflix Model’ to wipe out hep c. but at what price? MedCity News / 27 October 2019 Cost of Hepatitis C Drug Skyrockets 1,422% after Patent Approval Folha de S.Paulo / 24 October 2019 Gilead’s stealing hep C share with its cut-rate Epclusa and Harvoni generics Fierce Pharma / 23 September 2019 GSK to develop Ionis hepatitis B drugs PM LIve / 30 August 2019 Louisiana is creating a drug-price revolution The Hill / 21 May 2019 Gilead gets 'gold' in England's hepatitis C eradication drive PMLive / 21 May 2019 ← First12345...22Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive